Gene · 64919
BCL11B: BCL11 transcription factor B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BCL11B: BCL11 transcription factor B. Genes, record 64919. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/64919
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9C0K0 | B-cell lymphoma/leukemia 11B | 894 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents40
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 38662 | Q9C0K0 | Espacenet |
| JP 2025164846 A | 2025-10-30 | 42 | Q9C0K0 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7353 | Q9C0K0 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14791 | Q9C0K0 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7353 | Q9C0K0 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8444 | Q9C0K0 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 25133 | Q9C0K0 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 25136 | Q9C0K0 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14791 | Q9C0K0 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 14791 | Q9C0K0 | Espacenet |
1 to 10 of 40
See all 40 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,751
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BCL11B papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 20 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 15 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 12 | 2025 |
| R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 9 | 2025 |
| U10CA180886 | COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement | 8 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
| R01MH113257 | Yale Macaque Brain Resource | 7 | 2025 |
| R35NS116843 | Continuous Neurogenesis in the Mammalian Hippocampus | 7 | 2025 |
| U10CA180899 | Children's Oncology Group Statistics and Data Center | 7 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 6 | 2025 |
1 to 10 of 2,751Source NIH's project files
See all 2,751 nih grantsPapers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BCL11B predetermines a persister state in breast cancer that is reversed by TNFα. | Sci Adv | 2026 | 42715302 | PubTator, text mining | PubMed |
| ALA-PDT for giant condyloma acuminatum in an immunodeficient child with BCL11B mutation: safety and efficacy. | Photodiagnosis Photodyn Ther | 2026 | 42674263 | PubTator, text mining | PubMed |
| Benzo[a]pyrene-induced AHR activation in human ESCs primes premature neurogenesis in cerebral organoids. | J Hazard Mater | 2026 | 42667716 | PubTator, text mining | PubMed |
| BCL11B targeting in tumor CD8 + T cells amplifies anti-tumor response by blocking exhaustion while promoting stemness and cytotoxicity. | bioRxiv | 2026 | 42601873 | PubTator, text mining | PubMed |
| The Bcl11-Cxxc1 axis regulates stage-specific chromatin accessibility during lymphocyte development. | Genes Dev | 2026 | 42547288 | PubTator, text mining | PubMed |
| Bcl11b dose-dependently regulates positive selection of CD8 T cells to the virtual memory fate. | bioRxiv | 2026 | 42465258 | PubTator, text mining | PubMed |
| RNA-binding protein RALYL-mediated BCL11B RNA stability promotes immune escape in small cell lung cancer through transcriptional activation of BUB3. | Cell Oncol (Dordr) | 2026 | 42455237 | PubTator, text mining | PubMed |
| miR-132 overexpression is associated with modulation in miR-21 expression and glioblastoma cell behavior. | PLoS One | 2026 | 42430385 | PubTator, text mining | PubMed |
| iPSC Neurodegenerative Disease Initiative isogenic CAG repeat iPSC line for Huntington's disease. | bioRxiv | 2026 | 42427629 | PubTator, text mining | PubMed |
| Palmitic acid-induced metabolic stress alters differentiation-associated gene expression in human ameloblast-like cells. | Biochem Biophys Res Commun | 2026 | 42398335 | PubTator, text mining | PubMed |
1 to 10 of 2,697
See all 2,697 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/64919
GET https://conductscience.org/api/genes/v1/64919/patents?page=2